Elepsia XR FDA Approval History
FDA Approved: Yes (First approved December 20, 2018)
Brand name: Elepsia XR
Generic name: levetiracetam
Dosage form: Extended-Release Tablets
Company: Sun Pharmaceutical Industries Inc.
Treatment for: Epilepsy
Elepsia XR (levetiracetam) is an extended-release formulation of the antiepileptic drug levetiracetam designed to reduce pill burden in patients receiving high doses for the treatment of partial onset seizures.
Development timeline for Elepsia XR
| Date | Article |
|---|---|
| Sep 25, 2015 | Approval Sun Pharma Advanced Research Company Ltd. Receives Complete Response Letter for Elepsia XR |
| Mar 4, 2015 | Approval Sun Pharma Announces FDA Approval of Elepsia XR (levetiracetam) Extended-Release Tablets |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
